Prof. Dr. Michael Torzewski | Institut für klinische Pharmakologie IKP

Major Networks and Collaborations

Ulrich F. W. Franke, Department of Cardiovascular Surgery, Robert Bosch Hospital, Stuttgart, Germany
Matthias Schwab, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
Sotirios Tsimikas, Department of Medicine, University of California San Diego
Arnold von Eckardstein, Institute of Clinical Chemistry, University of Zurich and University Hospital of Zurich, Zurich, Switzerland

Selected References

Capoulade, R., Torzewski M, Mayr M, K. L. Chan, P. Mathieu, Y. Bossé, J. G. Dumesnil, J. Tam, K. K. Teo, S. A. Burnap, J. Schmid, N. Gobel, U. F. W. Franke, A. Sanchez, J. L. Witztum, X. Yang, C. Yeang, B. Arsenault, J. P. Després, P. Pibarot and S. Tsimikas S. ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis. Heart 2020; 106(10): 738-745

Singh, S. and Torzewski M. Fibroblasts and Their Pathological Functions in the Fibrosis of Aortic Valve Sclerosis and Atherosclerosis. Biomolecules 2019; 9(9)

Reustle, A. and Torzewski M. Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis. Int J Mol Sci 2018; 19(12)

Cheng Fei, Twardowski Laura, Fehr Sarah, Aner Christoph, Schaeffeler Elke, Joos Thomas, Knorpp Thomas, Dorweiler Bernhard, Laufer Stefan, Schwab Matthias, Torzewski Michael. Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: Implications for atherosclerosis. FASEB J. 2017;31(2):674-686. doi: 10.1096/fj.201600669R. PMID: 27871059.

Torzewski, M., A. Ravandi, C. Yeang, A. Edel, R. Bhindi, S. Kath, L. Twardowski, J. Schmid, X. Yang, U. F. W. Franke, J. L. Witztum and S. Tsimikas. Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC Basic Transl Sci 2017; 2(3): 229-240

Twardowski L, Cheng F, Michaelsen J, Winter S, Hofmann U, Schaeffeler E, Muller S, Sonnenberg M, Steuer K, Ott G, Schwab M, Franke U F, Torzewski M. Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease. J Am Heart Assoc. 2015;4(10). doi: 10.1161/JAHA.115.002156.

Education and Professional Career

March 19th, 2012

recognition as specialist in Medical Microbiology

June 21th, 2011

extraordinary professorship at the Johannes Gutenberg-University Mainz

Since April1st 2011

head of Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, Stuttgart

Aug. 2009-March 2011

director, Institute of Clinical Chemistry and Hematology (IKCH), Institute of Clinical Microbiology and Immunology (IKMI), St. Gallen, Switzerland

since Oct. 2006

postgraduate distance learning programme (Master´s degree programme) in Health and Social Service Management, Technical University of Kaiserslautern (Distance and International Studies Center)

May 21th, 2008

recognition as specialist in Neuropathology

April 20th, 2006

recognition as Clinical Chemist

since Sep. 16th, 2004

“Oberarzt” (senior physician) at the Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University Mainz (head: Prof. Dr. K. J. Lackner)

June 3rd, 2004

“Habilitation” (postdoctoral lecture qualification) in Clinical Chemistry and Laboratory Medicine

April 28th, 2004

recognition as specialist in Laboratory Medicine

Oct. 2003-March 2004

further education in internal medicine, Department of Medicine III, Hematology and Oncology, Johannes Gutenberg-University Mainz (head: Prof. Dr. Ch. Huber)

Oct. 2002-Sep. 2003

further education in medical microbiology, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University Mainz (head: Prof. Dr. S. Bhakdi)

since April 2002

assistant doctor, Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University Mainz (head: Prof. Dr. K. J. Lackner)

Sep. 2001-Feb. 2002

postdoc, Specialized Center of Research on Atherosclerosis (SCOR) (head: Joseph L. Witztum, Professor of Medicine), Department of Medicine, University of California San Diego (UCSD)

Jan. 1999-March 2002

assistant doctor, Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg (head: Prof. Dr. G. Schmitz)

July 1994-Dec.1998

assistent doctor, Institute of Pathology, Heinrich-Heine-University Düsseldorf (head: Prof. Dr. H. E. Gabbert)

June 1st, 1994

“Approbation” (licence to practice medicine)

Dec.1993-June 1994

medical assistent, Institute of Anatomy and Special Embryology, University Fribourg/Switzerland (head: Prof. Dr. Dr. G. Rager)

Dec.1992-Nov.1993

resident at the Department of Neurosurgery of the Sankt Gertrauden Hospital Berlin-Wilmersdorf (head: Prof. Dr. B. Bingas)

Nov. 10th, 1992

doctorate (Department of Pharmacology, University of Mainz)

Oct. 1992

“3. Staatsexamen” (medical examination)

Oct.1986-Oct.1992

medicine studies, University of Mainz

Scholarships and Scientific Awards

2005

recipient of the „Robert-Müller-Forschungspreis“ awarded by the medical faculty of the Johannes Gutenberg-University Mainz

2005

recipient of the „W. H. Hauss-Preis“ awarded by the German section of the International Atherosclerosis Society (DGAF)

2000

„Heinz Meise-Preis“ awarded by the Deutschen Herzstiftung: Torzewski M et al.: Deposition of C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent recruitment of monocytes in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20: 2094-2099

1999

recipient of the poster award of the German United Society of Clinical Chemistry and Laboratory Medicine (DGKL)

1989-1992

studentship of the Cusanuswerk, scholarhip organization sponsoring talented students